Spire Healthcare Group (LON:SPI) Trading Down 20% – Here’s Why

Spire Healthcare Group plc (LON:SPI)’s stock price dropped 20% during trading on Monday . The stock traded as low as GBX 148.83 and last traded at GBX 151.80. Approximately 45,061,531 shares were traded during mid-day trading, an increase of 1,005% from the average daily volume of 4,078,339 shares. The stock had previously closed at GBX 189.74.

Spire Healthcare Group Trading Down 18.1%

The company’s fifty day simple moving average is GBX 193.65 and its two-hundred day simple moving average is GBX 205.56. The company has a market capitalization of £625.28 million, a price-to-earnings ratio of 33.78, a price-to-earnings-growth ratio of 1.06 and a beta of 0.71. The company has a quick ratio of 0.74, a current ratio of 0.63 and a debt-to-equity ratio of 177.14.

Spire Healthcare Group (LON:SPI) last announced its quarterly earnings results on Friday, March 6th. The company reported GBX 9.60 earnings per share (EPS) for the quarter. Spire Healthcare Group had a net margin of 1.04% and a return on equity of 2.22%. Research analysts forecast that Spire Healthcare Group plc will post 15.6634747 earnings per share for the current fiscal year.

Spire Healthcare Group Company Profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments.